The antimalarials are one of the most commonly prescribed drugs in medical practice, for conditions such as rheumatoid arthritis as well as malaria. They are generally well-tolerated and the possible side effects of synthetic antimalarials, though infrequent, are well known. Besides the familiar adverse reactions, a localized mucocutaneous bluish-grey to black discolouration can sometimes be seen with antimalarial drugs. The aim of this report was to draw attention to the localized mucocutaneous bluish-grey hyperpigmentation induced by hydroxychloroquine with a case presentation and a review of the literature.
%0 Journal Article
%1 citeulike:14277614
%A Melikoglu, M. A.
%A Melikoglu, M.
%A Gurbuz, U.
%A Budak, B. S.
%A Kacar, C.
%D 2008
%J Journal of clinical pharmacy and therapeutics
%K citeulikeExport dermatology, drug, hydroxychloroquine, hyperpigmentation, pigmentation, side-effect
%N 6
%P 699--701
%T Hydroxychloroquine-induced hyperpigmentation: a case report.
%U http://view.ncbi.nlm.nih.gov/pubmed/19138249
%V 33
%X The antimalarials are one of the most commonly prescribed drugs in medical practice, for conditions such as rheumatoid arthritis as well as malaria. They are generally well-tolerated and the possible side effects of synthetic antimalarials, though infrequent, are well known. Besides the familiar adverse reactions, a localized mucocutaneous bluish-grey to black discolouration can sometimes be seen with antimalarial drugs. The aim of this report was to draw attention to the localized mucocutaneous bluish-grey hyperpigmentation induced by hydroxychloroquine with a case presentation and a review of the literature.
@article{citeulike:14277614,
abstract = {{The antimalarials are one of the most commonly prescribed drugs in medical practice, for conditions such as rheumatoid arthritis as well as malaria. They are generally well-tolerated and the possible side effects of synthetic antimalarials, though infrequent, are well known. Besides the familiar adverse reactions, a localized mucocutaneous bluish-grey to black discolouration can sometimes be seen with antimalarial drugs. The aim of this report was to draw attention to the localized mucocutaneous bluish-grey hyperpigmentation induced by hydroxychloroquine with a case presentation and a review of the literature.}},
added-at = {2019-03-31T01:14:40.000+0100},
author = {Melikoglu, M. A. and Melikoglu, M. and Gurbuz, U. and Budak, B. S. and Kacar, C.},
biburl = {https://www.bibsonomy.org/bibtex/24b2b4e8b096fd9066f4d567e092f7ae0/dianella},
citeulike-article-id = {14277614},
citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/19138249},
citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=19138249},
interhash = {fcb0d561494ba05d730fed1db04a0059},
intrahash = {4b2b4e8b096fd9066f4d567e092f7ae0},
issn = {1365-2710},
journal = {Journal of clinical pharmacy and therapeutics},
keywords = {citeulikeExport dermatology, drug, hydroxychloroquine, hyperpigmentation, pigmentation, side-effect},
month = dec,
number = 6,
pages = {699--701},
pmid = {19138249},
posted-at = {2017-02-12 23:13:59},
priority = {2},
timestamp = {2019-03-31T01:16:26.000+0100},
title = {{Hydroxychloroquine-induced hyperpigmentation: a case report.}},
url = {http://view.ncbi.nlm.nih.gov/pubmed/19138249},
volume = 33,
year = 2008
}